209 related articles for article (PubMed ID: 21047416)
1. Soluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells.
Muthusamy A; Cooper CR; Gomes RR
BMC Biochem; 2010 Nov; 11():43. PubMed ID: 21047416
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity.
Teran M; Nugent MA
J Biol Chem; 2015 Jun; 290(26):16451-62. PubMed ID: 25979342
[TBL] [Abstract][Full Text] [Related]
3. Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds.
Yang WD; Gomes RR; Alicknavitch M; Farach-Carson MC; Carson DD
Tissue Eng; 2005; 11(1-2):76-89. PubMed ID: 15738663
[TBL] [Abstract][Full Text] [Related]
4. Low molecular weight fucoidan increases VEGF165-induced endothelial cell migration by enhancing VEGF165 binding to VEGFR-2 and NRP1.
Lake AC; Vassy R; Di Benedetto M; Lavigne D; Le Visage C; Perret GY; Letourneur D
J Biol Chem; 2006 Dec; 281(49):37844-52. PubMed ID: 17028197
[TBL] [Abstract][Full Text] [Related]
5. Heparin regulates vascular endothelial growth factor165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells. Comparison of the effects of heparin and modified heparins.
Ashikari-Hada S; Habuchi H; Kariya Y; Kimata K
J Biol Chem; 2005 Sep; 280(36):31508-15. PubMed ID: 16027124
[TBL] [Abstract][Full Text] [Related]
6. The interaction of heparan sulfate proteoglycans with endothelial transglutaminase-2 limits VEGF165-induced angiogenesis.
Beckouche N; Bignon M; Lelarge V; Mathivet T; Pichol-Thievend C; Berndt S; Hardouin J; Garand M; Ardidie-Robouant C; Barret A; Melino G; Lortat-Jacob H; Muller L; Monnot C; Germain S
Sci Signal; 2015 Jul; 8(385):ra70. PubMed ID: 26175493
[TBL] [Abstract][Full Text] [Related]
7. Endorepellin laminin-like globular 1/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cells.
Willis CD; Poluzzi C; Mongiat M; Iozzo RV
FEBS J; 2013 May; 280(10):2271-84. PubMed ID: 23374253
[TBL] [Abstract][Full Text] [Related]
8. Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability.
Xu D; Fuster MM; Lawrence R; Esko JD
J Biol Chem; 2011 Jan; 286(1):737-45. PubMed ID: 20974861
[TBL] [Abstract][Full Text] [Related]
9. Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
Héroult M; Bernard-Pierrot I; Delbé J; Hamma-Kourbali Y; Katsoris P; Barritault D; Papadimitriou E; Plouet J; Courty J
Oncogene; 2004 Mar; 23(9):1745-53. PubMed ID: 15001987
[TBL] [Abstract][Full Text] [Related]
10. Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis.
Zoeller JJ; Whitelock JM; Iozzo RV
Matrix Biol; 2009 Jun; 28(5):284-91. PubMed ID: 19422911
[TBL] [Abstract][Full Text] [Related]
11. The vascular endothelial growth factor VEGF165 induces perlecan synthesis via VEGF receptor-2 in cultured human brain microvascular endothelial cells.
Kaji T; Yamamoto C; Oh-i M; Fujiwara Y; Yamazaki Y; Morita T; Plaas AH; Wight TN
Biochim Biophys Acta; 2006 Sep; 1760(9):1465-74. PubMed ID: 16914267
[TBL] [Abstract][Full Text] [Related]
12. Exogenous recombinant dimeric neuropilin-1 is sufficient to drive angiogenesis.
Uniewicz KA; Cross MJ; Fernig DG
J Biol Chem; 2011 Jan; 286(1):12-23. PubMed ID: 20956519
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic antithrombin blocks the heparan sulfate-dependent binding of proangiogenic growth factors to their endothelial cell receptors: evidence for differential binding of antiangiogenic and anticoagulant forms of antithrombin to proangiogenic heparan sulfate domains.
Zhang W; Swanson R; Xiong Y; Richard B; Olson ST
J Biol Chem; 2006 Dec; 281(49):37302-10. PubMed ID: 17040907
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.
Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S
Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941
[TBL] [Abstract][Full Text] [Related]
15. Neuropilin-1 and neuropilin-2 enhance VEGF121 stimulated signal transduction by the VEGFR-2 receptor.
Shraga-Heled N; Kessler O; Prahst C; Kroll J; Augustin H; Neufeld G
FASEB J; 2007 Mar; 21(3):915-26. PubMed ID: 17185751
[TBL] [Abstract][Full Text] [Related]
16. Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells.
Gitay-Goren H; Cohen T; Tessler S; Soker S; Gengrinovitch S; Rockwell P; Klagsbrun M; Levi BZ; Neufeld G
J Biol Chem; 1996 Mar; 271(10):5519-23. PubMed ID: 8621410
[TBL] [Abstract][Full Text] [Related]
17. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
[TBL] [Abstract][Full Text] [Related]
18. Regulation of pathologic retinal angiogenesis in mice and inhibition of VEGF-VEGFR2 binding by soluble heparan sulfate.
Nishiguchi KM; Kataoka K; Kachi S; Komeima K; Terasaki H
PLoS One; 2010 Oct; 5(10):e13493. PubMed ID: 20975989
[TBL] [Abstract][Full Text] [Related]
19. Perlecan Domain V induces VEGf secretion in brain endothelial cells through integrin α5β1 and ERK-dependent signaling pathways.
Clarke DN; Al Ahmad A; Lee B; Parham C; Auckland L; Fertala A; Kahle M; Shaw CS; Roberts J; Bix GJ
PLoS One; 2012; 7(9):e45257. PubMed ID: 23028886
[TBL] [Abstract][Full Text] [Related]
20. Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor.
Dougher AM; Wasserstrom H; Torley L; Shridaran L; Westdock P; Hileman RE; Fromm JR; Anderberg R; Lyman S; Linhardt RJ; Kaplan J; Terman BI
Growth Factors; 1997; 14(4):257-68. PubMed ID: 9386990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
